Model based analysis of the heterogeneity in the tumour size dynamics differentiates vemurafenib, dabrafenib and trametinib in metastatic melanoma

PURPOSE: Explore the heterogeneity in dynamics of tumour response to vemurafenib, dabrafenib and trametinib using routinely collected clinical trial imaging data. METHODS: Time-series imaging data from the phase III studies of vemurafenib, dabrafenib and trametinib were collected through a data repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mistry, Hitesh B., Orrell, David, Eftimie, Raluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778167/
https://www.ncbi.nlm.nih.gov/pubmed/29222604
http://dx.doi.org/10.1007/s00280-017-3486-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778167/
https://www.ncbi.nlm.nih.gov/pubmed/29222604
http://dx.doi.org/10.1007/s00280-017-3486-3

Ejemplares similares